Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Ping An Leads $70 Million Round in MeMed, an Israeli Diagnostics Company

publication date: Sep 21, 2018

Ping An Global Voyager Fund invested $20 million in Israeli diagnostic company MeMed as part of MeMed's $70 million C round. MeMed has developed MeMed BV, a blood test that distinguishes between bacterial and viral infections based on analysis of three immune system components. MeMed will use the capital to market its MeMed BV test and to develop MeMed Key, a point-of-care protein measurement system, and other innovative immune system tests based on machine learning. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital